Bone and Renal Safety Are Improved in Chronic HBV Patients 1 Year after Switching to Tenofovir Alafenamide (TAF) from Tenofovir Disoproxil Fumarate (TDF)
Yazar
Streinu-Cercel, Adrian
Seto, Wai Kay Walter
Buti, Maria
Izumi, Namiki
Lim, Young-Suk
Kao, Jia-Horng
Nurmukhametova, Elena
Ma, Xiaoli
Jablkowski, Maciej
Suri, Vithika
Flaherty, John F.
Lau, Audrey H.
Gaggar, Anuj
Mo, Shuyuan
Chowdhury, Abhijit
Fung, Scott K.
Chuang, Wan-Long
Gane, Edward J.
Tabak, Fehmi
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]